
Share
A new law in Connecticut aims to protect hospitals and communities by banning sale-leaseback transactions, a practice that has been linked to financial instability and reduced quality of care.
On May 27, Connecticut Governor Ned Lamont signed into law a groundbreaking bill that places strict limitations on private equity’s influence over hospitals. Senate Bill 196, effective February 15, 2027, includes a first-of-its-kind ban on hospital sale-leaseback transactions-a practice often criticized for leading to financial distress and reduced quality of care.
The law requires hospitals to attest that they have no controlling interest from private equity firms, no governance control by such entities, and no mandates that interfere with clinician decision-making. However, the most notable provision is the flat ban on sale-leaseback transactions starting July 1, 2027. This means hospitals will no longer be able to sell their real estate and lease it back, a tactic often used by private equity firms to extract value from health systems.
While other states have taken steps to limit private equity’s role in healthcare, Connecticut's law is the first to directly target sale-leaseback transactions. According to a representative from the Private Equity Stakeholder Project (PESP), a nonprofit that scrutinizes private equity deals and advocates for greater transparency, this is a significant step.
“While Massachusetts indirectly limited some hospital sale-leasebacks by preventing public health departments from granting licenses to hospitals leasing their main campus from real estate investment trusts, Connecticut’s bill is the first to explicitly restrict the practice,” the PESP representative explained.
The move comes in response to growing concerns about the impact of private equity on healthcare. Critics argue that these firms often prioritize short-term profits over long-term patient care and community health. The bankruptcy of Prospect Medical Systems in January 2025, which left several Connecticut hospitals struggling, is a recent example that has galvanized action.

The implications of this law are far-reaching. For hospitals, the ban on sale-leasebacks means they will need to find alternative ways to manage their real estate and financial resources. This could lead to more sustainable business practices but may also require creative solutions to maintain operations and services.
For patients and communities, the law aims to ensure that healthcare facilities remain focused on providing high-quality care rather than generating profits for private equity investors. The PESP representative noted that this could help prevent the kind of financial instability and service disruptions seen in other regions where private equity has played a significant role.
However, the law is not without its critics. Some industry groups argue that it may limit hospitals' flexibility to manage their assets effectively and could make it harder for them to secure funding for necessary improvements or expansions. The debate highlights the ongoing tension between financial sustainability and patient care in the healthcare sector.
As other states watch Connecticut’s approach, this law could serve as a model for broader policy changes aimed at protecting healthcare systems from the potential downsides of private equity involvement. The coming months will be crucial in determining the law's impact and whether it can indeed safeguard hospitals and communities while maintaining financial stability.
Tags
Original Sources
New Connecticut private equity law bans hospital sale-leasebacks
↗ https://www.fiercehealthcare.com/providers/new-connecticut-private-equity-law-bans-hospital-sale-leasebacks
About the author
Amara's entry point into AI was an epidemiology role at a London research hospital, where she spent five years studying how digital health tools reached — or conspicuously failed to reach — underserved communities. Watching early algorithmic systems in healthcare quietly entrench existing inequalities, she redirected her career toward the systemic consequences of AI at scale. She covers AI through an unflinching lens: who benefits, who bears the cost, and what evidence actually says versus what the press release claims. Her writing is calm and precise, but she doesn't mistake balance for neutrality.
More from The Steward →This Week's Edition
8 June 2026
67 articles
Related Articles

Pope's Encyclical on AI Raises Ethical Questions for Catholic Hospitals
Policy & Regulation · 4 min

AI Giants Lobby Congress for DNA Data Safeguards in Biotech Boom
Policy & Regulation · 4 min

Utah Medical Board Reprimanded for Criticizing AI-Powered Prescription Renewal Pilot
Policy & Regulation · 3 min
Related Articles

Pope's Encyclical on AI Raises Ethical Questions for Catholic Hospitals
Policy & Regulation · 4 min

AI Giants Lobby Congress for DNA Data Safeguards in Biotech Boom
Policy & Regulation · 4 min

Utah Medical Board Reprimanded for Criticizing AI-Powered Prescription Renewal Pilot
Policy & Regulation · 3 min
More Stories
© 2026 Cedar & Bloom. All rights reserved.